Form 4: Mesa Laboratories CFO John Sakys Reports Stock Transactions
SEC Form 4 Filing
John Sakys, CFO of Mesa Laboratories, reports the vesting and disposal of restricted stock units and common stock transactions.
Summary
- On June 14, 2024, John Sakys, the CFO of Mesa Laboratories, engaged in transactions involving the company's stock.
- These transactions included the vesting of 1,304 Restricted Stock Units (RSUs) and the disposal of 572 shares of common stock to cover tax obligations.
- Following these transactions, Sakys directly owns 11,463 shares of common stock and indirectly owns 100 shares as a custodian.
- He also owns 793 Restricted Stock Units.
Sentiment
Score: 5
Explanation: This is a routine disclosure of insider transactions, with no indication of positive or negative sentiment. It reflects standard compensation practices.
Industry Context
Form 4 filings are standard practice for reporting insider transactions, providing transparency to investors regarding the buying and selling activities of company executives and directors.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect standard executive compensation and tax obligations.
Key Dates
| Date | Description |
|---|---|
| September 1, 2022 | 1/3 of certain RSUs vested |
| June 15, 2023 | 1/3 of certain RSUs vested |
| June 14, 2024 | Date of stock transactions: vesting of RSUs and disposal of shares. |
| June 15, 2024 | 1/3 of certain RSUs vested |
| June 17, 2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.